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ABSTRACT 
Among thyroid papillary carcinomas (PTC), the follicular variant is the most common and includes 
encapsulated forms (EFVPTC). Non-invasive EFVPTC have very low risk of tumor recurrence or 
other adverse events and have been recently proposed to be designated as “Non-invasive follicular 
thyroid neoplasm with papillary-like nuclear features” or “NIFTP”, thus eliminating the term 
“carcinoma”. This proposal is expected to significantly impact the risk of malignancy associated 
with the diagnostic categories currently used to report thyroid cytology. In this study, we analyzed 
the FNAB cytology features of 96 histologically proven NIFTP and determine how the main 
nuclear features of NIFTP correlate between cytologic and histologic samples. Blind review of 
FNAB cytology from NIFTP nodules yielded the diagnosis of “follicular neoplasm” (Bethesda 
category IV) in 56% of cases, “suspicious for malignancy” (category V) in 27%, “atypia of 
undetermined significance/follicular lesion of undetermined significance” (category III) in 15%, 
and “malignant” (category VI) in 2%. We found good correlation (k=0.62) of nuclear features 
between histological and cytological specimens. Nuclear features (size, irregularities of contours 
and chromatin clearing) of NIFTP were significantly different from those of benign nodules, but not 
from those of invasive EFVPTC. Our data indicate that most of NIFTP nodules yield an 
indeterminate cytological diagnosis in FNAB cytology and nuclear features found in cytology 
samples are reproducibly identified in corresponding histology samples. Because of the overlapping 
nuclear features with invasive EFVPTC, NIFTP cannot be reliably diagnosed preoperatively, but 
should be listed in differential diagnosis of all indeterminate categories of thyroid cytology.  
KEY WORDS: thyroid cancer, thyroid nodules, follicular variant papillary carcinoma, 
encapsulated, cytology, NIFTP  
INTRODUCTION 
Cancer of the thyroid gland is the most common endocrine malignant neoplasm, and papillary 
thyroid carcinoma (PTC) accounts for the vast majority of cases. Generally, PTC has a favorable 
prognosis, with long-term survival rates in excess of 95% [1]. It is well documented that the 
substantial increase of the incidence of thyroid cancer is mainly due to early detection of neoplasms 
with indolent behavior, mainly small cancers (microcarcinomas) or the use of more relaxed 
histopathologic criteria for the follicular variant of PTC (FVPTC) [2, 3]. 
In particular, the encapsulated form of FVPTC (EFVPTC) [4] accounts for 10-20% of all thyroid 
cancers currently diagnosed in Europe and North America [5, 6]. The pathological diagnosis of this 
variant is associated with a high degree of inter-observer variability and discordance [7, 8], because 
it is mainly based on the detection of nuclear features of PTC, which are frequently less evident 
than in classical PTC. The correct recognition of this entity is thus very subjective. In addition, 
EFVPTC is known to have an indolent behavior [5, 9, 10]. Cases with incomplete evidence of 
papillary type nuclei have been either assigned to the category of PTC, or downgraded to follicular 
adenoma or a category of well differentiated tumors of uncertain malignant potential (WDT-UMP), 
as suggested by some European authors [11-14].  
A recent multi-institutional study examined a large cohort of a well-annotated EFVPTC and 
established that none of 109 patients with non-invasive EFVPTC followed for 10-26 years 
developed recurrence or other disease manifestations [3]. Based on this information, the 
international multidisciplinary group of authors recommended to reclassify these tumors as “non-
invasive follicular thyroid tumor with papillary-like nuclear features” (NIFTP). NIFTP is defined by 
a set of reproducible diagnostic criteria that include nuclear features of the papillary carcinoma, 
such as nuclear size, nuclear membrane irregularities, as well as chromatin clearing (ground-glass 
appearance), found in a non-invasive encapsulated follicular-patterned tumor.  
Fine needle aspiration biopsy (FNAB) is the most important and reliable diagnostic procedure for 
pre-operative evaluation of a thyroid nodule. At present, most thyroid FNAB specimens are 
classified according to the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) 
which includes six diagnostic categories, each of them corresponding to a different risk of 
malignancy [15]. Other classification systems are currently in use in Europe, including those 
proposed by the British Thyroid Society [16] and by the Italian SIAPEC [17], both of them 
comprising six diagnostic categories, as well. Several previous reports pointed out the challenges in 
the cytological diagnosis of the FVPTC due to partially overlapping features with both benign and 
malignant follicular-patterned lesions [14, 18]. 
Although histologic features of NIFTP have been well characterized [3], how reliably these features 
can be identified in pre-operative cytology samples remains unknown. Furthermore, it remains to be 
determined what cytological diagnoses the NIFTP nodules will yield in thyroid FNAB and what 
will be an impact of reclassification of non-invasive EFVPTC on the risk of malignancy in the 
categories of the Bethesda system. A recent multicentric study suggested that by excluding non-
invasive encapsulated FVPTC, many of which are expected now to be diagnosed as NIFTP, the risk 
of malignancy will decrease significantly in the three indeterminate cytology categories (Bethesda 
III through V) [19]. In addition, such reclassification will have a profound impact on patient 
management, as the lesions classified as NIFTP will not require completion thyroidectomy or post-
surgical radioiodine therapy. In this study, we provide a detailed analysis of a large series of NIFTP 
from three Italian institutions in order to characterize their cytological features and correlate them 
with histologic outcomes. 
MATERIALS AND METHODS 
Case selection - Cases of NIFTP were retrospectively collected from six different hospitals of three 
Italian institutions (Universities of Turin, Bologna and Pisa). Before revision, cyto-histological 
cases were matched and each slide was anonymized and coded by a pathology staff member not 
involved in the study. Histological materials filed under the original diagnosis of encapsulated 
FVPTC, WDT-UMP or follicular adenoma with occasional clear nuclei were examined. Criteria for 
inclusion were: i) histological diagnosis of NIFTP according to the reported criteria (see below) [3], 
and ii) availability of an adequate FNAB biopsy sample performed in the same thyroid nodule. In 
detail, the diagnostic criteria for NIFTP included the follicular growth pattern, complete 
encapsulation, no invasion, and papillary cancer type nuclei [3]. The latter were assessed by 
evaluating three nuclear parameters: (a) size and shape (enlargement/overlapping/crowding and 
elongation), (b) membrane irregularities (irregular contours, grooves and pseudoinclusions), and (c) 
chromatin characteristics (chromatin clearing with margination, glassy nuclei). Criteria for 
exclusion were: vascular invasion or extrathyroidal extension, capsular infiltration (or incomplete/
absent capsule) or the presence of a papillary architecture in more than 1% of the tumor. No 
multifocal tumors were included, with the exception of 2 cases with incidentally found papillary 
microcarcinoma <5 mm in size.  After histologic slide review, 96 cases of NIFTP were identified: 
an initial set of 55 from the University Hospitals in Turin (20 from Molinette Hospital, 8 from 
Mauriziano Hospital and 27 from San Luigi Hospital), 21 cases from Bologna (Maggiore and 
Bellaria Hospitals), and 20 cases from the Santa Chiara Hospital in Pisa. A portion (14/21) of the 
NIFTP cases from Bologna had already been included in the original histological series of NIFTP 
cases [3]. 
For comparison, benign follicular lesions and invasive EFVPTC with adequate FNAB samples were 
also included. The former group (37 cases from Molinette Hospital) was represented by 
microfollicular hyperplastic goiter (19 cases) and conventional (non-oncocytic) follicular adenoma 
(18). The invasive EFVPTC cases (24 cases from Molinette and Santa Chiara Hospitals in Turin 
and Pisa, respectively) had vascular or capsular or parenchymal invasion. The 20 cases from Pisa 
had already been included in the original histological series as EFVPTC with invasion [3]. 
Case review - All FNAB cytology cases and corresponding surgical specimens were reviewed 
independently by the local senior pathologists (MP, MV, GT, GC, FB), and all of them were re-
screened by two pathologists (FrM, FeM) together with the contributing pathologist from each 
Institution. The nuclear score was determined, and for each of the three nuclear parameters, a 
percentage of expression was assigned, reflecting the extent of the abnormality observed (size/
shape, nuclear membrane profile, chromatin appearance). Score 0 was assigned if the single 
parameter was absent or present in <50% of cells. Score 1 was assigned if the parameter was clearly 
evident in >50% of cells. The sum of the three scores yielded a final value of 0 to 3. 
In all cases, alcohol-fixed or air-dried smears, stained with hematoxylin and eosin (H&E) or 
Papanicolaou or Giemsa were available for evaluation. In addition, in 92 cases, 4 µm-thick sections 
obtained from alcohol-fixed, paraffin-embedded cell-blocks stained with H&E or Papanicolaou 
were available for review. FNAB cytological features from 55 histologically confirmed NIFTP and 
61 benign or malignant tumors were assessed blindly, i.e. without knowing the histologic diagnoses. 
The presence/absence of the following parameters was recorded: (i) nuclear enlargement (at least 
twice the size of a red blood cell); (ii) nuclear membrane abnormalities (irregularities of contour, 
pseudoinclusions, grooves); (iii) optically clear, ground-glass nuclei; (iv) nuclear molding; (v) 
exclusive presence of microfollicular pattern (no macrofollicles); (vi) colloid; (vii) prominent 
nucleoli; (viii) fibrous tissue; (ix) associated macrophages; (x) loosely cohesive cellularity; (xi) 
tridimensional clusters of follicular cells; (xii) high cellularity. For the first three parameters, the 
extent to which each parameter was represented was recorded as a percentage. In order to parallel 
the evaluations performed on the corresponding histologica l cases, a score 0 was assigned if the 
single parameter was absent or present in <50% of cells and score 1 if the parameter was present in 
>50% of cells, thus yielding a final sum of the three scores from 0 to 3. In some cases, the 
percentage of nuclear irregularities could not be reliably assessed due to low cellularity, fixation 
artifact, poorly-stained or partly obscured follicular cells. In these cases, the cytological score was 
assessed on the basis of the presence/absence of a single parameter, without considering the 50% 
cut-off.  
CD56 Immunohistochemistry - In a subset of cases, immunocytochemistry for CD56 (clone 
123C3, Ventana Medical Systems, Tucson, USA, diluted 1/100) was performed on cell-blocks. For 
each case, a percentage of positive cells was assessed. Cases with >80% of positive cells were 
considered diffusely positive, while cases showing a range of positive cells between 1 and 80% 
were considered focally positive; cases with no positive cells were considered negative [20, 21]. 
Statistical analysis - Fisher’s exact or Chi-square and Student’s t tests, for categorical and 
continuous variables, respectively, were performed to select the cytological parameters associated to 
the diagnosis of NIFTP, versus benign and malignant tumors, to compare nuclear scores between 
the groups, to correlate nuclear score and Bethesda categorization, and to compare CD56 
immunoreactivity in different tumor types.. A test of concordance (Cohen’s kappa) was used to 
calculate the agreement between histological and cytological scores. The correlation between the 
extent of the nuclear changes in cytological and histological samples was made using a two tailed 
Spearman’s test.  Statistical significance was set at a level of 0.05. All analyses were conducted 
using.SPSS statistical package . 
RESULTS 
Cytological diagnosis of NIFTP nodules in FNA samples - The results of blind review of 
cytology FNAB from nodules histologically diagnosed as NIFTP, benign nodules, and invasive 
EFVPTC are summarized in Table 1. Following the Bethesda System for reporting, most (56%) of 
NIFTP nodules were diagnosed as “suspicious for a follicular neoplasm” (category IV), followed by 
“suspicious for malignancy” (category V) (27%), and “atypia of undetermined significance/
follicular lesion of undetermined significance” (category III) (15%). Only 2.1% cases were called 
“malignant” (category VI). On the contrary, benign follicular adenomas and microfollicular 
hyperplastic nodules were diagnosed as Bethesda category IV (54%) or category III (46%), while 
invasive EFVPTC were typically diagnosed as Category IV (62.5%) or Category V (37.5%).   
Nuclear score evaluation in histological samples - All 55 NIFTP cases in the initial set had a 
nuclear score of 2 (21 cases) or 3 (34 cases), while benign nodules were scored 0 or 1 and invasive 
EFVPTC were scored 2 or 3. The mean percentage of nuclear irregularities was significantly 
different (Student t-test, P=10-xx) between NIFTP and benign follicular lesions for each of the three 
parameters (92.9% vs 21.3% for nuclear size, 72.4% vs 4.3% for nuclear membrane irregularities 
and 63.8% vs 6.2% for chromatin clearing). Conversely, the differences between NIFTP and 
invasive EFVPTC were not statistically significant (the latter having mean percentages of 84.2%, 
72.9% and 61.7% for enlarged nuclear size, membrane irregularities, and chromatin clearing, 
respectively).  
Nuclear score evaluation in cytological samples - Among all cytological parameters analyzed, 
nuclear enlargement, nuclear membrane irregularities, optically clear/ground-glass nuclei and 
nuclear molding were significantly associated to NIFTP diagnosis, irrespective of being evaluated 
in smears, cell-blocks or both (Table 2). A significantly different mean percentage of nuclear 
alterations (Student t-test, P=xxx) was found between NIFTP cases and benign follicular lesions for 
each of the three parameters (63.8% vs 33.5% for nuclear size, 69.6% vs 10.3% for nuclear 
membrane irregularities and 53.9% vs 10% for chromatin clearing). Conversely, as for histological 
samples, no significant differences were found in FNAB of NIFTP and invasive EFVPTC (Table 3  
In NIFTP, FNAB samples most frequently had a nuclear score of 2 (22 cases) or 3 (n 19 cases), 
whereas benign follicular lesions had nuclear score 0 in 23 cases, score 1 in 12 cases, and score 2 in 
2 cases. Invasive EFVPTC showed the nuclear score of 3 or 2. Comparing the distribution of scores 
(from 0 to 3) a significant difference was found only between NIFTP and follicular lesions (chi-
square test P<0.05 VALORE ESATTO), but not between NIFTP cases and invasive EFVPTC (chi-
square test P=0.15). 
Cytological-histological correlations  - In cytological samples, comparing the nuclear scores 
grouped as 0-1 vs 2-3 with the Bethesda System categories for NIFTP and other lesions (Table 4) a 
significant correlation was found only for NIFTP (chi-square test P<0.001). In the whole series, the 
degree of agreement between cytological and histological scoring was good (Cohen’s kappa= 0.62, 
95% confidence interval 0.49-0.74) (Table 5). Examples of cytol-histological correlation are shown 
in Figure 1. Comparing paired cytological and histological samples among all lesion types, a 
significant correlation was found in the recognition of nuclear enlargement (Spearman r= 0.430, 
P<0.05), nuclear membrane irregularities (Spearman r= 0.794, P<0.05) and of optically clear nuclei 
(Spearman r= 0.648, P<0.05). A significant, although weaker, correlation was maintained in the 
restricted group of NIFTP (Spearman r= 0.316, P<0.05 for nuclear enlargement; Spearman r= 
0.605, P<0.05 for nuclear membrane irregularities; Spearman r= 0.401, P<0.05 for optically clear 
nuclei).  
CD56 expression - In FNABs of NIFTP, CD56 had a variable expression, with 20/36 (55%) 
negative tumors, similar to classical papillary carcinoma. The remaining cases had CD56 
expression either diffuse (>80% of cells) in 10/36 (28%) or focal (10 to 25% of cells) in 6 (17%) 
cases. Benign nodules were CD56 positive either diffusely in 29/36 (80%) cases, or focally (30% of 
cells) in 2 (6%), and negative in 5 (14%) cases (Figure 2). There was significant difference between 
NIFTP and benign follicular lesions (chi-square test P<0.001), supporting the notion that NIFTP has 
a CD56 expression profile intermediate between follicular adenoma and papillary cancer. 
DISCUSSION 
In this study, we report for the first time the cytological features and diagnoses for tumors that 
histologically belong to a recently described entity of “Non-invasive follicular tumor with papillary 
type nuclei” (NIFTP) [3]. The results of our analysis indicate that despite heterogeneous expression 
of nuclear features of papillary carcinoma in the NIFTP nodules, a significant correlation of nuclear 
features is present between histological and cytological samples in the majority of case. Overall, the 
most common cytologic diagnosis rendered in FNAB of histologically proven NIFTP nodules is 
“follicular neoplasm” (Bethesda IV). However, a number of cases had sufficiently evident nuclear 
features to suggest a diagnosis of suspected malignancy, while in single cases the diagnosis of a 
papillary carcinoma could be rendered. 
In histological specimens, NIFTP is defined as a non-invasive, encapsulated follicular-patterned 
tumor with cytological features of papillary carcinoma. According to the initial description, the 
presence of papillary carcinoma type nuclei in NIFTP is heterogeneous in terms of both qualitative 
and quantitative changes. A nuclear score offered for diagnosing these tumors in the resected 
specimens is based on the identification of enlarged nuclei, irregular nuclear borders and chromatin 
clearing [3]. Assigning a value of 1 to each detected parameter, a NIFTP diagnosis requires at least 
two of the three above features, thus determining a score of 2 or 3. In this study, we find that these 
features, either all of the three or at least chromatin clearing and irregular borders, can be 
recognized in FNAB cytology samples, provided that sufficient cellularity is obtained in either 
smears or cell-blocks or both. More unpredictable is the recognition of such parameters in the 
NIFTP cases that have focal or only occasional papillary-type nuclei. In those case, the cytological 
diagnosis Bethesda IV or even III is frequently given. 
We found a good correlation between nuclear scores detected in surgical specimens and those in 
FNAB cytology material. Among specific features, nuclear membrane irregularities had the best 
correlation. In FNAB cytology specimens, irrespective of being smears or cell-blocks available, the 
tumor cell size was the least well performing feature, perhaps due to the difficulty of reliably 
scoring nuclear size in cytology. Of interest, classical features of papillary carcinoma, such as 
nuclear vacuoles and grooves, were not invariably present in NIFTP. In addition, in some cases of 
NIFTP, papillary carcinoma-type nuclear features may not be well evident and the co-existence of 
cell clusters containing follicular cells with dark slightly enlarged nuclei with smooth border 
prevents the cytologic diagnosis of suspicious for malignancy, and instead prompts diagnosing these 
samples as “Follicular neoplasm”/Bethesda IV. 
Overall, among the three groups of follicular-patterned lesions with known surgical pathology 
diagnosis studied in this series, most were diagnosed in FNAB samples as either “follicular 
neoplasm or suspicious for follicular neoplasm” or “atypia of undetermined significance/follicular 
lesion of undetermined significance” according to the Bethesda system. One of these two cytologic 
diagnoses was rendered in 100% of benign follicular adenomas/microfollicular goiter nodules, in 
63% of invasive EFVPTC, and in 71% of NIFTP cases. However, about one-fourth of NIFTP were 
interpreted as “suspicious for malignancy” and two tumors as malignant. When compared with the 
resected specimen, the two cases diagnosed by cytology as malignant had complete encapsulation 
with no invasion and a follicular architecture with cells having large, markedly irregular nuclei, 
diffuse clearing of chromatin and scattered nuclear pseudoinclusions and grooves. The existence of 
such cases raises a possibility that in a cytological sample that lacks evidence of papillary 
architecture, the finding of even fully developed PTC nuclei cannot exclude the possibility of 
NIFTP diagnosis after surgery. Since this new terminology is expected to replace a significant 
proportion of cases previously classified as EFVPTC, this clinical scenario may be relatively 
common. In a recent study, the impact of reclassifying non-invasive encapsulated follicular variant 
papillary carcinomas, now designated as NIFTP, on the risk of cancer predicted by FNAB cytology 
was investigated [19]. It showed that the risk is expected to be reduced in all categories of 
indeterminate cytology, including atypia of indeterminate significance, follicular neoplasm, and 
suspicious for malignancy. The current study confirms this expectation directly. As a result, the 
changes in the reporting of FNAB and predicting the risk of malignancy in these categories of 
cytology defined by the Bethesda system diagnostic category will be needed. 
Importantly, NIFTP appears to have a very indolent behavior, with the risk of recurrence less than 
1% in 10 years, as opposed to invasive encapsulated FVPTC that can metastasize and result in 
patient death [3, 11]. Since the detection of invasion requires surgical excision, this will likely to 
remain an appropriate therapeutic approach for these tumors. However, in the absence of invasion, 
it appears that neither completion of thyroidectomy, nor radioiodine treatment is required.  
Among additional diagnostic modalities, molecular tests of FNAB material may be useful to 
distinguish conventional invasive PTC, which more likely to contain BRAF mutations or RET/PTC 
rearrangements, from pure follicular patterned neoplasms with papillary type nuclei, including 
invasive EFVPTC and NIFTP, which frequently carry RAS mutations or PAX8-PPARG fusions [3]. 
However, whether molecular genotyping can provide high sensitivity and specificity of NIFTP 
diagnosis in FNAB sample remains to be elucidated. CD56, a neural adhesion molecule expressed 
in different cells and tumors, including endocrine tumors, was recently proposed as a differential 
marker to separate follicular tumors from PTC, with the latter being negative [21]. CD56 expression 
was found to be heterogeneous in this series of NIFTP, with an intermediate profile between 
follicular and papillary cancers, thus supporting the view that NIFTP shares cytomorphological 
features with PTC, although CD56 loss was not as complete as reported in conventional PTC [21, 
22]. 
In conclusion, in this study we observed good correlation of cytological nuclear features between 
histological and cytological specimens of NIFTP. Moreover, although this tumor cannot be 
diagnosed with certainty based on FNAB cytology, we showed that nuclear features of NIFTP are 
significantly different from those of benign follicular tumors and hyperplastic nodules, but not from 
those of EFVPTC with invasion. Therefore, the presence of papillary carcinoma-type nuclei in a 
follicular-patterned nodule observed in FNAB cytology should indicate the possibility of not only 
PTC, but also NIFTP. This could affect the extent of surgery since patients with NIFTP are at very 
low risk for unfavorable outcome after the nodule excision by hemithyroidectomy. 
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Table legends 
Table 1. Clinical data and cytological categorization of FNAB according to the Bethesda System. 
Table 2. FNAB cytology parameter assessment in NIFTP and benign follicular lesions 
* P<0.05 was considered statistically significant. 
Table 3. Occurrence of the three most relevant FNAB cytology parameters in NIFTP and other 
lesions. 
NOTE. The P-value assesses the differences in the extent of the three parameters between NIFTP 
and benign follicular lesions (*) and between NIFTP and invasive EFVPTC (**) 
Table 4. Correlation between nuclear score and categorization according to the Bethesda System in 
different tumor types. 
NOTE.  The chi-square test showed significant correlation between nuclear score and Bethesda 
categorization in the NIFTP category (Chi-square: 32.999, P<0.001) 
Table 5. Concordance of scores between FNAB cytology and histology in the whole series of 
lesions studied. 
Figure legends 
Figure 1. Illustrations of the nuclear features and nuclear scores in cytological and histological 
material from a follicular adenoma and two cases of NIFTP. The follicular adenoma shows small 
nuclei (less than twice the size of a red blood cell) (A, alcohol-fixed smear stained with H&E; 
x400), without chromatin clearing (B, alcohol-fixed H&E-stained smear; x400) and with round, 
regular contours (C, air-dried Giemsa-stained smear; x400). The corresponding histological sample 
(D, H&E; x400) shows a microfollicular lesion with small, dark and round, regular nuclei, not 
significantly different from the normal thyroid around the nodule (inset). The second column 
exemplifies a case of NIFTP with large (E, air-dried smear stained with Giemsa; x400), but dark 
nuclei (F, alcohol-fixed Pap-stained smear; x400); anyway, irregularities of nuclear contours with 
grooves could be appreciated (G, alcohol-fixed Pap-stained smear; x400). The corresponding 
histological sample (H, H&E; x400) shows large and irregular, but prevalently dark nuclei, if 
compared to normal thyroid (inset). The third column illustrates a case of NIFTP with nuclear score 
3 on both cytological (alcohol-fixed Pap-stained smear in I,L and H&E-stained in M; x400) and 
histological samples (N, H&E; x400).  
Figure 2. CD56 immunostaining results in a case of microfollicular goiter (A,B), showing CD56 
intense and diffuse membranous positivity (B) and in a case of NIFTP (C,D), showing a complete 
loss of expression of CD56 in neoplastic cells. Sections obtained from cell-blocks and stained with 
H&E (A,C; x400) and antibodies anti-CD56 (B,D; x400).  
Table 1. Clinical data and cytological categorization of FNAB according to the Bethesda System 
No
.
Age 
(yrs, 
median
)
Sex Size (cm, 
mean)
Cytological categories according to 
the Bethesda System
F M II III (%) IV (%) V (%) VI (%)
NIFTP 96 46 70 26 2.6 0 14 (15) 54 (56) 26 (27) 2 (2)
 Benign follicular 
lesions
37 62 22 15 3.2 0 17 (46) 20 (54) 0 0
Invasive 
EFVPTC
24 43 15 9 2.2 0 0 15 (62.5) 9 (37.5) 0
Table 2. FNAB cytology parameter assessment in NIFTP and benign follicular lesions 
* P<0.05 was considered statistically significant. 
 
NIFTP Benign follicular 
lesions
Fisher’s exact test 
P-value
Nuclear enlargement 37/55 14/37 0.0098*
Nuclear membrane irregularities 47/55 1/37 0.0001*
Optically clear, ground-glass nuclei 29/55 1/37 0.0001*
Nuclear molding 50/55 20/37 0.0001*
Microfollicular pattern only              
(no macrofollicles)
48/55 10/37 0.1037
Colloid 7/55 8/37 0.2678
Prominent nucleoli 15/55 17/37 0.077
Fibrous tissue 22/55 21/37 0.1384
Associated macrophages 12/55 11/37 0.4642
Loosely cohesive cellularity 39/55 28/37 0.6422
3D clusters of follicular cells 3/55 2/37 1
High cellularity 15/55 10/37 1
Table 3. Occurrence of the three most relevant FNAB cytology parameters in NIFTP and other 
lesions  
NOTE. The P-value assesses the differences in the extent of the three parameters between NIFTP 
and benign follicular lesions (*) and between NIFTP and invasive EFVPTC (**)
N. Nuclear size Nuclear membrane 
irregularities
Chromatin 
clearing
mean range mean range mean range
NIFTP 55 63.8 0-100 69.6 0-100 53.9 0-100
Benign follicular 
lesions
37 33.5 0-100 10.3 0-60 10 0-70
P-value * <0.05 <0.05 <0.05
Invasive EFVPTC 24 66.2 0-100 80 30-100 55 0-100
P-value ** >0.05 >0.05 >0.05
Table 4. Correlation between nuclear score and categorization according to the Bethesda System in 
different tumor types. 
NOTE.  The chi-square test showed significant correlation between nuclear score and Bethesda 
categorization in the NIFTP category (Chi-square: 32.999, P<0.001) 
Tumor type (N of cases) Nuclear Score  
(N of cases) 
Categorization according to Bethesda System
III IV V VI
NIFTP (96)
Score 0-1 (22) 12 9 1 0
Score 2-3 (74) 2 45 25 2
Benign follicular lesions 
(37)
Score 0-1 (35) 16 19 0 0
Score 2-3 (2) 1 1 0 0
Invasive EFVPTC (24)
Score 0-1 (2) 0 2 0 0
Score 2-3 (22) 0 13 9 0
Table 5. Concordance of scores between FNAB cytology and histology in the whole series of 
thyroid lesions studied. 
Histology
Cytology
Score 0-1 Score 2-3
Score 0-1 35 24
Score 2-3 2 96
Cohen’s kappa 0.62 (IC 95% 0.49-0.74)
